tiprankstipranks
Pascal Biosciences Inc (TSE:NEVI)
CNQX:NEVI

Pascal Biosciences Inc (NEVI) Financial Statements

3 Followers

Pascal Biosciences Inc Financial Overview

Pascal Biosciences Inc's market cap is currently ―. The company's EPS TTM is C$-0.008; its P/E ratio is -13.48; Pascal Biosciences Inc is scheduled to report earnings on October 18, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 23May 23Feb 23Nov 22Aug 22
Income Statement-
Total RevenueC$ 275.67KC$ 58.00C$ 17.59K-C$ 0.00
Gross ProfitC$ 131.29KC$ 58.00C$ 17.59K--
EBITC$ 19.17KC$ -83.21KC$ -132.63KC$ -201.45KC$ -94.02K
EBITDAC$ 47.95KC$ -83.21KC$ -132.63KC$ -199.18KC$ -93.46K
Net Income Common StockholdersC$ 10.66KC$ -83.21KC$ -132.63KC$ -201.45KC$ -94.73K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 575.14KC$ 153.70KC$ 10.41KC$ 8.37KC$ 16.91K
Total AssetsC$ 2.66MC$ 175.27KC$ 25.68KC$ 18.82KC$ 167.02K
Total DebtC$ 670.51KC$ 325.21KC$ 300.16KC$ 224.62KC$ 215.65K
Net DebtC$ 95.36KC$ 171.51KC$ 289.75KC$ 216.25KC$ 198.75K
Total LiabilitiesC$ 1.10MC$ 1.18MC$ 1.10MC$ 962.93KC$ 913.84K
Stockholders EquityC$ 1.57MC$ -1.01MC$ -1.07MC$ -944.11KC$ -746.83K
Cash Flow-
Free Cash FlowC$ -166.13KC$ -31.76KC$ -73.50KC$ -17.50KC$ -50.12K
Operating Cash FlowC$ -160.95KC$ -31.78KC$ -80.75KC$ -25.84KC$ -50.12K
Investing Cash FlowC$ -940.33KC$ 22.00C$ 7.24KC$ 8.34K-
Financing Cash FlowC$ 1.51MC$ 175.05KC$ 75.54KC$ 8.96KC$ 40.96K
Currency in CAD

Pascal Biosciences Inc Earnings and Revenue History

Pascal Biosciences Inc Debt to Assets

Pascal Biosciences Inc Cash Flow

Pascal Biosciences Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis